Skip to main content
SpringerLink
Log in

Association of Multiple sclerosis with Other Autoimmune Diseases

  • Chapter
  • First Online:
Multiple Sclerosis Immunology

  • 1564 Accesses

Abstract

Since its first comprehensive clinico-pathological description by Charcot, Multiple sclerosis (MS) has remained a mysterious clinical entity and has represented a fascination to scientists and clinicians of the most diverse disciplines. With an incompletely known pathogenesis and aetiology, it has given rise to numerous theories including the more plausible ones of infection, autoimmunity and primary neurodegenerative disease to the more daring ones of vascular disease, psychological abnormality or even neurocristopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology 53(3):457–465

    Google Scholar 

  • (2000) Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet 355(9207):873–876

    Google Scholar 

  • (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23(8):857–866

    Google Scholar 

  • Achari AN, Trontelj JV et al (1976) Multiple sclerosis and myasthenia gravis. A case report with single fiber electromyography. Neurology 26(6 PT 1):544–546

    Article  PubMed  CAS  Google Scholar 

  • Alsalameh S, Manger B et al (1998) New onset of rheumatoid arthritis during interferon beta-1B treatment in a patient with multiple sclerosis: comment on the case report by Jabaily and Thompson. Arthritis Rheum 41(4):754

    Article  PubMed  CAS  Google Scholar 

  • Anaya JM (2010) The autoimmune tautology. Arthritis Res Ther 12(6):147

    Article  PubMed  Google Scholar 

  • Anaya JM (2012) Common mechanisms of autoimmune diseases (the autoimmune tautology). Autoimmun Rev 11(11):781–784

    Article  PubMed  CAS  Google Scholar 

  • Antony JM, Deslauriers AM et al (2011) Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochim Biophys Acta 1812(2):162–176

    Article  PubMed  CAS  Google Scholar 

  • Arnett HA, Mason J et al (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4(11):1116–1122

    Article  PubMed  CAS  Google Scholar 

  • Ascherio A, Munger KL (2007a) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61(4):288–299

    Article  Google Scholar 

  • Ascherio A, Munger KL (2007b) Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 61(6):504–513

    Article  CAS  Google Scholar 

  • Bahmanyar S, Montgomery SM et al (2009) Cancer risk among patients with multiple sclerosis and their parents. Neurology 72(13):1170–1177

    Article  PubMed  CAS  Google Scholar 

  • Ballou SP, Khan MA et al (1982) Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum 25(1):55–60

    Article  PubMed  CAS  Google Scholar 

  • Barcellos LF, Kamdar BB et al (2006) Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 5(11):924–931

    Article  PubMed  CAS  Google Scholar 

  • Becker MD, Heiligenhaus A et al (2005) Interferon as a treatment for uveitis associated with multiple sclerosis. Br J Ophthalmol 89(10):1254–1257

    Article  PubMed  CAS  Google Scholar 

  • Behan PO, Chaudhuri A (2010) The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy. Inflammopharmacology 18(6):265–290

    Article  PubMed  Google Scholar 

  • Berkovich R, Subhani D et al (2011) Autoimmune comorbid conditions in multiple sclerosis. US Neurology 7(2):132–138

    Google Scholar 

  • Bernatsky S, Renoux C et al (2010) Demyelinating events in rheumatoid arthritis after drug exposures. Ann Rheum Dis 69(9):1691–1693

    Article  PubMed  CAS  Google Scholar 

  • Braitch M, Harikrishnan S et al (2009) Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol Scand 119(4):239–245

    Article  PubMed  CAS  Google Scholar 

  • Coles AJ, Compston DA et al (2008) Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med 359(17):1786–1801

    Article  PubMed  Google Scholar 

  • Collard RC, Koehler RP et al (1997) Frequency and significance of antinuclear antibodies in multiple sclerosis. Neurology 49(3):857–861

    Article  PubMed  CAS  Google Scholar 

  • Constantinescu CS (1995) Melanin, melatonin, melanocyte-stimulating hormone, and the susceptibility to autoimmune demyelination: a rationale for light therapy in multiple sclerosis. Med Hypotheses 45(5):455–458

    Article  PubMed  CAS  Google Scholar 

  • Constantinescu CS, Goodman DB et al (1997) Serum angiotensin-converting enzyme in multiple sclerosis. Arch Neurol 54(8):1012–1015

    Article  PubMed  CAS  Google Scholar 

  • Constantinescu CS, Gran B (2010) Multiple sclerosis: autoimmune associations in multiple sclerosis. Nat Rev Neurol 6(11):591–592

    Article  PubMed  CAS  Google Scholar 

  • Constantinescu CS, Ventura E et al (1995) Effects of the angiotensin converting enzyme inhibitor captopril on experimental autoimmune encephalomyelitis. Immunopharmacol Immunotoxicol 17(3):471–491

    Article  PubMed  CAS  Google Scholar 

  • Correale J, Farez M (2007) Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 61(2):97–108

    Article  PubMed  CAS  Google Scholar 

  • Cossburn M, Pace AA et al (2011) Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology 77(6):573–579

    Article  PubMed  CAS  Google Scholar 

  • d’Hennezel E, Ben-Shoshan M et al (2009) FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N Engl J Med 361(17):1710–1713

    Article  PubMed  Google Scholar 

  • de Seze J, Canva-Delcambre V et al (2005) Autoimmune hepatitis and multiple sclerosis: a coincidental association? Mult Scler 11(6):691–693

    Article  PubMed  Google Scholar 

  • Deal CL, Meenan RF et al (1985) The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum 28(9):987–994

    Article  PubMed  CAS  Google Scholar 

  • Disanto G, Chaplin G et al (2012) Month of birth, vitamin D and risk of immune mediated disease: a case control study. BMC Med 10(1):69

    Article  PubMed  CAS  Google Scholar 

  • Edwards LJ, Constantinescu CS (2004) A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 10(5):575–581

    Article  PubMed  CAS  Google Scholar 

  • Edwards LJ, Constantinescu CS (2009) Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases. Inflamm Allergy Drug Targets 8(3):182–190

    Article  PubMed  CAS  Google Scholar 

  • Edwards LJ, Dua H et al (2008) Symptomatic Uveitis and multiple sclerosis. Neuro-Ophthalmology 32(2):49–54

    Article  Google Scholar 

  • Elkon KB, Wiedeman A (2012) Type I IFN system in the development and manifestations of SLE. Curr Opin Rheumatol 24(5):499–505

    Article  PubMed  CAS  Google Scholar 

  • Font J, Cervera R et al (1998) Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57(8):456–459

    Article  PubMed  CAS  Google Scholar 

  • Frei K, Eugster HP et al (1997) Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 185(12):2177–2182

    Article  PubMed  CAS  Google Scholar 

  • Furszyfer J, Kurland LT et al (1972) Epidemiologic aspects of Hashimoto’s thyroiditis and Graves’ disease in Rochester, Minnesota (1935–1967), with special reference to temporal trends. Metabolism 21(3):197–204

    Article  PubMed  CAS  Google Scholar 

  • Ghezzi A (2004) Clinical characteristics of multiple sclerosis with early onset. Neurol Sci 25(Suppl 4):S336–S339

    Article  PubMed  Google Scholar 

  • Green AJ, McQuaid S et al (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133(Pt 6):1591–1601

    Article  PubMed  Google Scholar 

  • Gregorio GV, Portmann B et al (1997) Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 25(3):541–547

    Article  PubMed  CAS  Google Scholar 

  • Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California epidemiology of Uveitis study. Ophthalmology 111(3):491–500. (discussion 500)

    Article  PubMed  Google Scholar 

  • Hafler DA, Weiner HL (1989) MS: a CNS and systemic autoimmune disease. Immunol Today 10(3):104–107

    Article  PubMed  CAS  Google Scholar 

  • Hanrahan PS, Russell AS et al (1988) Ankylosing spondylitis and multiple sclerosis: an apparent association? J Rheumatol 15(10):1512–1514

    PubMed  CAS  Google Scholar 

  • Hansson I, Holmdahl R et al (1990) Constant darkness enhances autoimmunity to type II collagen and exaggerates development of collagen-induced arthritis in DBA/1 mice. J Neuroimmunol 27(1):79–84

    Article  PubMed  CAS  Google Scholar 

  • Haug K, Schrumpf E et al (1989) Epidemiology of Crohn’s disease in western Norway. Study group of Inflammatory Bowel Disease in Western Norway. Scand J Gastroenterol 24(10):1271–1275

    Article  PubMed  CAS  Google Scholar 

  • Hietaharju A, Peltola J et al (2001) The coexistence of systemic lupus erythematosus and multiple sclerosis in a mother and daughter. Scand J Rheumatol 30(2):120–122

    Article  PubMed  CAS  Google Scholar 

  • Hirschhorn JN, Lohmueller K et al (2002) A comprehensive review of genetic association studies. Genet Med 4(2):45–61

    Article  PubMed  CAS  Google Scholar 

  • Hofstetter HH, Ibrahim SM et al (2005) Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 237(2):123–130

    Article  PubMed  CAS  Google Scholar 

  • Hooper DC, Bagasra O et al (1997) Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A 94(6):2528–2533

    Article  PubMed  CAS  Google Scholar 

  • Hooper DC, Spitsin S et al (1998) Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 95(2):675–680

    Article  PubMed  CAS  Google Scholar 

  • Hugle T, Gratzl S et al (2009) Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced? Ann Rheum Dis 68(1):47–50

    Article  PubMed  CAS  Google Scholar 

  • Jacobson DL, Gange SJ et al (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84(3):223–243

    Article  PubMed  CAS  Google Scholar 

  • Jones JL, Coles AJ (2009) Spotlight on alemtuzumab. Int MS J 16(3):77–81

    PubMed  CAS  Google Scholar 

  • Jones JL, Phuah CL et al (2009) IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1 H). J Clin Invest 119(7):2052–2061

    PubMed  CAS  Google Scholar 

  • Komiyama Y, Nakae S et al (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177(1):566–573

    PubMed  CAS  Google Scholar 

  • Langer-Gould A, Albers KB et al (2010) Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler 16(7):855–861

    Article  PubMed  CAS  Google Scholar 

  • Lantz M, Abraham-Nordling M et al (2009) Immigration and the incidence of Graves’ thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma. Eur J Endocrinol 160(2):201–206

    Article  PubMed  CAS  Google Scholar 

  • Liu J, Marino MW et al (1998) TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4(1):78–83

    Article  PubMed  CAS  Google Scholar 

  • Magnano MD, Robinson WH et al (2004) Demyelination and inhibition of tumor necrosis factor (TNF). Clin Exp Rheumatol 22(5 Suppl35):S134–S140

    PubMed  CAS  Google Scholar 

  • Manica A, Prugnolle F et al (2005) Geography is a better determinant of human genetic differentiation than ethnicity. Hum Genet 118(3–4):366–371

    Article  PubMed  Google Scholar 

  • Marrie RA, Horwitz R et al (2009) Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology 72(2):117–124

    Article  PubMed  CAS  Google Scholar 

  • Mohan N, Edwards ET et al (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44(12):2862–2869

    Article  PubMed  CAS  Google Scholar 

  • Montgomery SM, Wakefield AJ et al (2003) Sex-specific risks for pediatric onset among patients with Crohn’s disease. Clin Gastroenterol Hepatol 1(4):303–309

    Article  PubMed  Google Scholar 

  • Munteis E, Cano JF et al (2007) Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort. Eur J Neurol 14(9):1048–1052

    Article  PubMed  CAS  Google Scholar 

  • Nielsen NM, Frisch M et al (2008) Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark. Mult Scler 14(6):823–829

    Article  PubMed  CAS  Google Scholar 

  • Nishimura M, Obayashi H et al (2000) Association between type 1 diabetes age-at-onset and intercellular adhesion molecule-1 (ICAM-1) gene polymorphism. Hum Immunol 61(5):507–510

    Article  PubMed  CAS  Google Scholar 

  • O’Sullivan JB, Cathcart ES (1972) The prevalence of rheumatoid arthritis. Follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts. Ann Intern Med 76(4):573–577

    Article  PubMed  Google Scholar 

  • Pelidou SH, Tsifetaki N et al (2007) Multiple sclerosis associated with systemic sclerosis. Rheumatol Int 27(8):771–773

    Article  PubMed  Google Scholar 

  • Pillemer SR, Matteson EL et al (2001) Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 76(6):593–599

    PubMed  CAS  Google Scholar 

  • Platten M, Youssef S et al (2009) Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci U S A 106(35):14948–14953

    Article  PubMed  CAS  Google Scholar 

  • Probert L, Akassoglou K et al (1997) TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J Neuroimmunol 72(2):137–141

    Article  PubMed  CAS  Google Scholar 

  • Ramagopalan SV, Dyment DA et al (2007a) Clustering of autoimmune disease in families at high risk for multiple sclerosis? Lancet Neurol 6(3):206–207. (author reply 207)

    Article  Google Scholar 

  • Ramagopalan SV, Dyment DA et al (2007b) Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol 6(7):604–610

    Article  Google Scholar 

  • Ramagopalan SV, Link J et al (2009) HLA-DRB1 and month of birth in multiple sclerosis. Neurology 73(24):2107–2111

    Article  PubMed  CAS  Google Scholar 

  • Ramos-Casals M, Roberto PAetal (2010) Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev 9(3):188–193

    Article  PubMed  CAS  Google Scholar 

  • Rolls AE, Giovannoni G et al (2010) Multiple sclerosis, lymphoma and nasopharyngeal carcinoma: the central role of Epstein-Barr virus? Eur Neurol 63(1):29–35

    Article  PubMed  Google Scholar 

  • Rose JD, Roberts GM et al (1988) Cardiff Crohn’s disease jubilee: the incidence over 50 years. Gut 29(3):346–351

    Article  PubMed  CAS  Google Scholar 

  • Schwartz M, Kipnis J (2005) Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J Neurol Sci 233(1–2):163–166

    Article  PubMed  CAS  Google Scholar 

  • Schwartz M, Shaked I et al (2003) Protective autoimmunity against the enemy within: fighting glutamate toxicity. Trends Neurosci 26(6):297–302

    Article  PubMed  CAS  Google Scholar 

  • Schwartz M, Shechter R (2010) Protective autoimmunity functions by intracranial immunosurveillance to support the mind: the missing link between health and disease. Mol Psychiatry 15(4):342–354

    Article  PubMed  CAS  Google Scholar 

  • Segal BM, Constantinescu CS et al (2008) Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 7(9):796–804

    Article  PubMed  CAS  Google Scholar 

  • Shoenfeld Y, Selmi C et al (2008) The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31(4):325–330

    Article  PubMed  Google Scholar 

  • Sloka JS, Phillips PW et al (2005). Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort. J Autoimmune Dis 2:9

    Article  PubMed  CAS  Google Scholar 

  • Somers EC, Thomas SL et al (2006) Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 17(2):202–217

    Article  PubMed  Google Scholar 

  • Stegbauer J, Lee DH et al (2009) Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci U S A 106(35):14942–14947

    Article  PubMed  CAS  Google Scholar 

  • Stevens DB, Swanborg RH (1993) Bromodeoxyuridine and light treatment deletes effector but not suppressor cells of autoimmune encephalomyelitis. J Neuroimmunol 44(2):177–184

    Article  PubMed  CAS  Google Scholar 

  • Stosic M, Ambrus J et al (2010) MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis. J Neurol 257(1):63–71

    Article  PubMed  Google Scholar 

  • Taams LS, Palmer DB et al (2006) Regulatory T cells in human disease and their potential for therapeutic manipulation. Immunology 118(1):1–9

    Article  PubMed  CAS  Google Scholar 

  • Taler M, Gil-Ad I et al (2011) The immunomodulatory effect of the antidepressant sertraline in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Neuroimmunomodulation 18(2):117–122

    Article  PubMed  CAS  Google Scholar 

  • Thorsby E, Lie BA (2005) HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl Immunol 14(3–4):175–182

    Article  PubMed  CAS  Google Scholar 

  • van Oosten BW, Barkhof F et al (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47(6):1531–1534

    Article  PubMed  Google Scholar 

  • Vilisaar J, Wilson M et al (2005) A comparative audit of anticardiolipin antibodies in oligoclonal band negative and positive multiple sclerosis. Mult Scler 11(4):378–380

    Article  PubMed  CAS  Google Scholar 

  • Vollmar P, Nessler S et al (2009) The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. Int J Neuropsychopharmacol 12(4):525–536

    Article  PubMed  CAS  Google Scholar 

  • Vollmer TL, Wynn DR et al (2011) A phase 2, 24-week, randomized, placebo-controlled, double-blind study examining the efficacy and safety of an anti-interleukin-12 and -23 monoclonal antibody in patients with relapsing-remitting or secondary progressive multiple sclerosis. Mult Scler 17(2):181–191

    Article  PubMed  CAS  Google Scholar 

  • Whitacre CC, Reingold SC et al (1999) A gender gap in autoimmunity. Science 283(5406):1277–1278

    Article  PubMed  CAS  Google Scholar 

  • Yuan XQ, Qiu G et al (2012) Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats. Neuroimmunomodulation 19(4):201–208

    Article  PubMed  CAS  Google Scholar 

  • Zamboni P (2006) The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med 99(11):589–593

    Article  PubMed  Google Scholar 

  • Zanelli E, Breedveld FC et al (2000) HLA association with autoimmune disease: a failure to protect? Rheumatology (Oxford) 39(10):1060–1066

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Neurosciences, University of Nottingham, C Floor, South Block, Queen’s Medical Centre, NG7 2UH, Nottingham, UK

    Ali Manouchehrinia, Laura J. Edwards & Cris S. Constantinescu

Authors
  1. Ali Manouchehrinia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura J. Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cris S. Constantinescu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cris S. Constantinescu .

Editor information

Editors and Affiliations

  1. National Institute of Neuroscience, National Center of Neurology and Psychia, Tokyo, Japan

    Takashi Yamamura

  2. Clinical Neurology, University of Nottingham, Nottingham, United Kingdom

    Bruno Gran

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Manouchehrinia, A., Edwards, L., Constantinescu, C. (2013). Association of Multiple sclerosis with Other Autoimmune Diseases. In: Yamamura, T., Gran, B. (eds) Multiple Sclerosis Immunology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7953-6_16

Download citation

Publish with us

Policies and ethics

Search

Navigation